IL2 and cancer: Various types of different liposomal formulations, including cationic, anionic, and neutral liposomes, have been explored for delivering IL-2 to cervical cancer cells, with CLs demonstrating high affinity for cancer cells and enhanced IL-2 cytotoxicity [161].